A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management of psoriatic arthritis
- 1 March 2012
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 71 (3) , 319-326
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapiesAnnals of the Rheumatic Diseases, 2012
- Long-term survival of methotrexate in psoriatic arthritisReumatismo, 2011
- A Comparison of the Efficacy and Safety of Celecoxib 200 mg and Celecoxib 400 mg Once Daily in Treating the Signs and Symptoms of Psoriatic ArthritisSeminars in Arthritis and Rheumatism, 2007
- The effectiveness of a traditional therapeutical approach in early psoriatic arthritis: results of a pilot randomised 6-month trial with methotrexateClinical Rheumatology, 2007
- Reduction of synovial sublining layer inflammation and proinflammatory cytokine expression in psoriatic arthritis treated with methotrexateArthritis & Rheumatism, 2004
- EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committeesAnnals of the Rheumatic Diseases, 2004
- Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A department of veterans affairs cooperative studyArthritis & Rheumatism, 1996
- Randomized, Double‐Blind, Placebo Controlled Trial of Low‐Dose Pulse Methotrexate in Psoriatic ArthritisArthritis & Rheumatism, 1984
- The run-in period in trial design: A comparison of two non-steroidal anti-inflammatory agents in psoriatic arthropathyInflammation Research, 1982
- Methotrexate Therapy in Psoriatic ArthritisJAMA, 1964